BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37083360)

  • 1. A Simple Kit Formulation for Preparation and Exploratory Human Studies of a Novel
    Ruan Q; Zhou C; Wang Q; Kang F; Jiang Y; Li G; Feng J; Zong S; Zhang J; Wang J
    Mol Pharm; 2023 Jun; 20(6):2942-2950. PubMed ID: 37083360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and Bioevaluation of
    Ruan Q; Feng J; Jiang Y; Zhang X; Duan X; Wang Q; Yin G; Xiao D; Zhang J
    Mol Pharm; 2022 Jan; 19(1):160-171. PubMed ID: 34904839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Development of
    Lindner T; Altmann A; Krämer S; Kleist C; Loktev A; Kratochwil C; Giesel F; Mier W; Marme F; Debus J; Haberkorn U
    J Nucl Med; 2020 Oct; 61(10):1507-1513. PubMed ID: 32169911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Preliminary Study of
    Ma M; Yang G; Zhao M; Liu Y; Ge X; Jia B; Gao S
    Mol Pharm; 2024 Feb; 21(2):735-744. PubMed ID: 38193393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Evaluation of
    Ruan Q; Wang Q; Jiang Y; Feng J; Yin G; Zhang J
    J Med Chem; 2023 Apr; 66(7):4952-4960. PubMed ID: 36972467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis and Preclinical Assessment of
    Trujillo-Benítez D; Luna-Gutiérrez M; Ferro-Flores G; Ocampo-García B; Santos-Cuevas C; Bravo-Villegas G; Morales-Ávila E; Cruz-Nova P; Díaz-Nieto L; García-Quiroz J; Azorín-Vega E; Rosato A; Meléndez-Alafort L
    Molecules; 2022 Jan; 27(1):. PubMed ID: 35011496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A radiohybrid theranostics ligand labeled with fluorine-18 and lutetium-177 for fibroblast activation protein-targeted imaging and radionuclide therapy.
    Yang T; Peng L; Qiu J; He X; Zhang D; Wu R; Liu J; Zhang X; Zha Z
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2331-2341. PubMed ID: 36864362
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Boschi A; Urso L; Uccelli L; Martini P; Filippi L
    EJNMMI Radiopharm Chem; 2024 May; 9(1):36. PubMed ID: 38695960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel molecular imaging probe [
    Jiang Y; Tian Y; Feng B; Zhao T; Du L; Yu X; Zhao Q
    Sci Rep; 2023 Mar; 13(1):3700. PubMed ID: 36879039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational Design and Comparison of Novel
    Meng L; Fang J; Zhang J; Li H; Xia D; Zhuang R; Chen H; Huang J; Li Y; Zhang X; Guo Z
    J Med Chem; 2024 May; 67(10):8460-8472. PubMed ID: 38717104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and Preclinical Testing of Tc-99m-Labeled HYNIC-Glc-FAPT as a FAP-Targeting Tumor Radiotracer.
    Yang X; Li G; Ruan C; Hu K; Tang G
    Bioconjug Chem; 2023 Nov; 34(11):2133-2143. PubMed ID: 37874952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Preclinical Evaluation of Novel
    Ruan Q; Ding D; Diao L; Feng J; Yin G; Jiang Y; Wang Q; Han P; Jiang J; Zhang J
    J Med Chem; 2024 Feb; 67(4):3190-3202. PubMed ID: 38320123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention.
    Loktev A; Lindner T; Burger EM; Altmann A; Giesel F; Kratochwil C; Debus J; Marmé F; Jäger D; Mier W; Haberkorn U
    J Nucl Med; 2019 Oct; 60(10):1421-1429. PubMed ID: 30850501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy.
    Pang Y; Zhao L; Fang J; Chen J; Meng L; Sun L; Wu H; Guo Z; Lin Q; Chen H
    J Nucl Med; 2023 Sep; 64(9):1449-1455. PubMed ID: 37321827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of
    Zhao L; Niu B; Fang J; Pang Y; Li S; Xie C; Sun L; Zhang X; Guo Z; Lin Q; Chen H
    J Nucl Med; 2022 Jun; 63(6):862-868. PubMed ID: 34556528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical Evaluation and a Pilot Clinical Positron Emission Tomography Imaging Study of [
    Du X; Gu B; Wang X; Wang X; Ji M; Zhang J; He S; Xu X; Yang Z; Song S
    Mol Pharm; 2024 Feb; 21(2):904-915. PubMed ID: 38179677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics.
    Wen X; Xu P; Shi M; Liu J; Zeng X; Zhang Y; Shi C; Li J; Guo Z; Zhang X; Khong PL; Chen X
    Theranostics; 2022; 12(1):422-433. PubMed ID: 34987657
    [No Abstract]   [Full Text] [Related]  

  • 18. Noninvasive imaging of FAP expression using positron emission tomography: A comparative evaluation of a [
    Huang J; Fu L; Zhang X; Huang S; Dong Y; Hu K; Han Y; Zhou K; Min C; Huang Y; Tang G
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3363-3374. PubMed ID: 37266596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
    Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O
    J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Li H; Ye S; Li Li ; Zhong J; Yan Q; Zhong Y; Feng P; Hu K
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2705-2715. PubMed ID: 35290473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.